NCT01103726View on ClinicalTrials.gov

Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Healthy
Interventions
DRUG

PF-02545920

1 and 5 mg tablets, 6 mg single dose

DRUG

placebo

matching placebo tablets, single dose

DRUG

PF-02545920

1 mg tablets, 3 mg single dose

DRUG

PF-02545920

5 mg tablets, 15 mg single dose

DRUG

Placebo

matching placebo tablets, single dose

Trial Locations (3)

06511

Pfizer Investigational Site, New Haven

06519

Pfizer Investigational Site, New Haven

06520

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
collaborator

Yale University

OTHER

lead

Pfizer

INDUSTRY